SecBot SecBot
SECBOTREPLAY Home › Report › COLL

COLL · Two directors at Collegium Pharmaceutical sold a combined $485K in…

COLLEGIUM PHARMACEUTICAL, INC · CLUSTER filed May 15, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed May 15, 2026 at 16:05 ET

Two directors at Collegium Pharmaceutical sold a combined $485K in open-market stock within 11 days of the company reporting strong Q1 2026 earnings (revenue +9% YoY, JORNAY PM +36%). The sales are small relative to the $1.1B market cap (~0.04%) and are not clustered with C-suite insiders, making them routine diversification trades rather than informed selling. The earnings report reaffirmed full-year guidance and highlighted the pending AZSTARYS acquisition, which is expected to close in Q2 2026.

  • Two directors sold a total of $485K in open-market shares over 4 days (May 11-13, 2026).
  • Sales represent ~0.04% of Collegium's $1.1B market cap, immaterial.
  • No C-suite insiders (CEO, CFO, etc.) sold shares in the cluster.
  • Q1 2026 earnings (filed May 7) showed net revenue of $193.5M (+9% YoY) and JORNAY PM revenue of $38.9M (+36% YoY).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access